Destination
Pfizer just had a big setback in its race for an Ozempic competitor

Pfizer (PFE) announced Monday that it is ending development of its daily weight-loss pill following a liver injury to a patient participating in a trial.Read more... [...]

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination
Tony Hogben, Immersive Studio Lead at Pfizer Digital Omnichannel Services & Solutions (OSS) – Interview Series

Tony Hogben is the Immersive Studio Lead at Pfizer Digital Omnichannel Services & Solutions (OSS). Pfizer Digital Omnichannel Services & Solutions (OSS) is at the forefront of transforming how [...]

Match Score: 69.16

Destination
Pfizer, drug companies make 'no commitments' to White House about lowering drug prices

Cheaper pharmaceuticals won’t be on shelves any time soon, says the CEO of Pfizer. That’s despite an executive order signed last month declaring a war on drug prices, which at one point President [...]

Match Score: 59.29

Destination
How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race

Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous w [...]

Match Score: 54.86

Destination
Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup

Novo Nordisk just cut the price of its weight-loss drug, Wegovy, by more than half for patients who pay without insurance. Amgen (AMGN) announced this week that it has begun two late-stage clinical tr [...]

Match Score: 34.75

Destination
Formula E will finally debut its fast-charging pit stops this weekend

After announcing initial plans two years ago, Formula E is finally ready to deploy its fast-charging pit stops in an official race. At the Jeddah E-Prix in Saudi Arabia this weekend, the all-electric [...]

Match Score: 31.86

blogspot
Ahrefs vs SEMrush: Which SEO Tool Should You Use?

SEMrush and Ahrefs are among<br /> the most popular tools in the SEO industry. Both companies have been in<br /> business for years and have thousands of customers per month.<br /> & [...]

Match Score: 30.75

thenextweb
Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy

London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biot [...]

Match Score: 29.93

Destination
Novo Nordisk's Ozempic successor disappointed Wall Street again

Novo Nordisk (NVO) released clinical trial results for its potential Ozempic successor on Monday, disappointing Wall Street for the second time.Read more... [...]

Match Score: 29.93

Destination
Insiders liken AI to "the Ozempic of the music industry" as hitmakers reportedly hide their generator use

The use of AI generators in professional music production is growing fast, but the industry would rather not talk about it. Top producers and songwriters are quietly embracing the technology behind th [...]

Match Score: 29.93